Citra Aryanti, Ronald Erasio Lusikooy, Samuel Sampetoding, Sachraswaty R Laidding, Warsinggih Warsinggih, Erwin Syarifuddin, Julianus Aboyaman Uwuratuw, Muhammad Ihwan Kusuma, Ibrahim Labeda, Murny Abdul Rauf
{"title":"Development and Validation of Machine Learning Model Platelet Index-based Predictor for Colorectal Cancer Stage.","authors":"Citra Aryanti, Ronald Erasio Lusikooy, Samuel Sampetoding, Sachraswaty R Laidding, Warsinggih Warsinggih, Erwin Syarifuddin, Julianus Aboyaman Uwuratuw, Muhammad Ihwan Kusuma, Ibrahim Labeda, Murny Abdul Rauf","doi":"10.31557/APJCP.2024.25.12.4425","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Colorectal cancer (CRC) staging is essential for effective treatment planning and prognosis. While platelet indices have shown promise in indicating CRC aggressiveness, a platelet index-based predictor for CRC staging has not been established in Indonesia. This study aimed to explore the relationship between platelet indices and CRC stage and to develop a predictive model and application.</p><p><strong>Methods: </strong>This cross-sectional study analyzed 369 CRC patients from Dr. Wahidin Sudirohusodo Hospital. Key parameters included age, gender, tumor location, and platelet indices: platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit, and the MPV/PC ratio. Data were processed using SPSS 25, MATLAB, and Streamlit.</p><p><strong>Results and discussion: </strong>The analysis revealed significant correlations between elevated platelet indices and advanced CRC stages. Various machine learning models were developed, with Support Vector Machine (SVM) achieving the highest accuracy at 82.9%, followed closely by K-Nearest Neighbors (82.7%), Neural Network (81.5%), Naive Bayes (80.5%), and logistic regression (51.5%). The most effective model was implemented as a portable application through Streamlit, yielding 79.2% internal validation and 89.2% external validation.</p><p><strong>Conclusion: </strong>This study highlights a significant association between increased platelet indices and advanced CRC stages. The innovative platelet index-based predictor for CRC staging offers promising potential for enhancing individualized clinical decision-making. By providing a non-invasive method that complements existing staging techniques, this approach could significantly improve patient outcomes through earlier and more accurate CRC staging. The findings underscore the importance of integrating simple, accessible biomarkers into clinical practice to enhance diagnostic precision.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"25 12","pages":"4425-4433"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2024.25.12.4425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Colorectal cancer (CRC) staging is essential for effective treatment planning and prognosis. While platelet indices have shown promise in indicating CRC aggressiveness, a platelet index-based predictor for CRC staging has not been established in Indonesia. This study aimed to explore the relationship between platelet indices and CRC stage and to develop a predictive model and application.
Methods: This cross-sectional study analyzed 369 CRC patients from Dr. Wahidin Sudirohusodo Hospital. Key parameters included age, gender, tumor location, and platelet indices: platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit, and the MPV/PC ratio. Data were processed using SPSS 25, MATLAB, and Streamlit.
Results and discussion: The analysis revealed significant correlations between elevated platelet indices and advanced CRC stages. Various machine learning models were developed, with Support Vector Machine (SVM) achieving the highest accuracy at 82.9%, followed closely by K-Nearest Neighbors (82.7%), Neural Network (81.5%), Naive Bayes (80.5%), and logistic regression (51.5%). The most effective model was implemented as a portable application through Streamlit, yielding 79.2% internal validation and 89.2% external validation.
Conclusion: This study highlights a significant association between increased platelet indices and advanced CRC stages. The innovative platelet index-based predictor for CRC staging offers promising potential for enhancing individualized clinical decision-making. By providing a non-invasive method that complements existing staging techniques, this approach could significantly improve patient outcomes through earlier and more accurate CRC staging. The findings underscore the importance of integrating simple, accessible biomarkers into clinical practice to enhance diagnostic precision.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.